Azilsartan Impurity 59, identified by its CAS number 1225044-11-0, is a chemical compound that serves as an impurity associated with the pharmaceutical agent azilsartan, which is primarily used for the treatment of hypertension. While specific characteristics such as molecular weight, structure, and solubility may not be widely documented in public databases, impurities like this are typically characterized by their potential impact on the efficacy and safety of the primary drug. Impurities can arise during the synthesis of pharmaceuticals and may affect the drug's stability, bioavailability, and overall therapeutic profile. In the context of drug development and quality control, understanding the properties of such impurities is crucial for ensuring compliance with regulatory standards. Analytical techniques such as chromatography and mass spectrometry are often employed to identify and quantify impurities like Azilsartan Impurity 59 in pharmaceutical formulations. Overall, the characterization of this impurity is essential for maintaining the integrity of azilsartan as a therapeutic agent.

Azilsartan Impurity 59

1225044-11-0: Azilsartan Impurity 59, identified by its CAS number 1225044-11-0, is a chemical compound that serves as an impurity associated with the pharmaceutical agent azilsartan, which is primarily used for the treatment of hypertension. While specific characteristics such as molecular weight, structure, and solubility may not be widely documented in public databases, impurities like this are typically characterized by their potential impact on the efficacy and safety of the primary drug. Impurities can arise during the synthesis of pharmaceuticals and may affect the drug's stability, bioavailability, and overall therapeutic profile. In the context of drug development and quality control, understanding the properties of such impurities is crucial for ensuring compliance with regulatory standards. Analytical techniques such as chromatography and mass spectrometry are often employed to identify and quantify impurities like Azilsartan Impurity 59 in pharmaceutical formulations. Overall, the characterization of this impurity is essential for maintaining the integrity of azilsartan as a therapeutic agent.

CAS 1225044-11-0

Azilsartan Impurity 59

1-((2-(1H-Diazirin-3-yl)-[1,1-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic Acid

Ref: ST-EA-CP-A36114